European Council of Homeopathy (ECCH)

European Council of Homeopathy (ECCH)

Home
The European Central Council of Homeopaths - Europe's leading resource for homeopathy
WELCOME! to the web-site of ECCH, the professional platform for the homeopathy profession in Europe made up of 27 member professional associations in 24 EU & EEA countries.
More introductory information about ECCH is available under Public Services  on this site. 
To find a list of national professional associations in Europe click on Find a homeopath
Visit ECCH on Facebook
Latest News:

18 November 2014

EU Antibiotics Awareness Day 2014: Time to take homeopathy and other CAM approaches more seriously

As the crisis over antimicrobial resistance increases and more people are dying, and are at risk of dying, from infectious illnesses no longer amenable to antibiotic treatment, it is time for homeopathy and other complementary medicine approaches to patient care to be taken more seriously.

On the occasion of EU Antibiotics Awareness Day when across the EU health practitioners and citizens are urged to use antibiotics far less in order to try to maintain antibiotic effectiveness, ECCH, together with its associates in EUROCAM, calls on the European Centre for Disease Control, the EU Commission, the European Parliament and all EU Member States to open their collective minds to the potential of Complementary and Alternative Medicine (CAM) to contribute to the fight to maintain antibiotic effectiveness. 

Please read the attached Press Release and Briefing Document from EUROCAM for further information.
press release eurocam ab awareness.pdf

eurocam - cam and amr def.pdf

23 October 2014


New report shows 60% of German citizens use homeopathic medicines - an increase of 7% since 2009             
 
New market data shows that over half the German population has used homeopathic medicines and that the number of users has gone up from 53% of the population in 2009 to 60% in 2014.
 
This report paints a rich picture of the use of these medicines in Germany with some interesting highlights:
·        73% of German women have used homeopathy and 48% of German men.
·        95% of West Germans know of homeopathic medicines, and this number has increased from 76% in 1975.
·        67% of users first decided to use homeopathy because of a recommendation from a friend or relative.
·        The most popular use is for colds and ‘flu, followed by ‘to strengthen the immune system,’ and for sun burn and insect bites. Other popular uses are headaches, indigestion, sleeplessness and stomach ache.
·        The main reason for choosing homeopathic medicines is the very low side incidence of effects.
 
This data is the result of a survey of about 1500 people in the whole of Germany in May and June this year, by the Institut  für Demoskopie Allensbach. A similar survey was last carried out in 2009.
 
Full details have been published by the German medicines manufacturing association, Bundesverband der Arzneimittel Hersteller (BAH) on their website: https://www.bah-bonn.de/presse-und-publikationen/pressemitteilungen/presse-detailseite/repraesentative-befragung-immer-mehr-menschen-nehmen-homoeopathika/
 
To download the report: https://www.bah-bonn.de/index.php?eID=dumpFile&t=f&f=4233&token=8724d36ab6615321300b76f723126d5e07d6e21e
 
For further information on Institut  für Demoskopie Allensbach: http://www.ifd-allensbach.de/

6 October 2014

EUROCAM publishes its revised vision for the integration of CAM into European healthcare

As the newly-elected European Parliament gradually gets its act together and the controversies around the proposed new EU Commission rumble on, EUROCAM the EU stakeholder group of users and professional providers of complementary and alternative medicine services across Europe has published a new vision for healthcare in Europe - 'CAM 2020'. Underpinning the vision for change is the understanding that a paradigmatic shift in healthcare needs to take place from one based on 'pathogenesis' to one based on 'salutogenesis'.

SALUTOGENESIS
'Salutogenesis' is a term coined by Aaron Antonovsky, a professor of medical sociology. The term describes an approach to healthcare focusing on factors that support human health and wellbeing, rather than on factors that cause disease. More specifically, the ‘salutogenic model’ is concerned with the relationship between health, stress, and coping. Salutogenesis explores the reasons why some people stay healthy in the face of hazardous influences whilst others, faced with similar pathogenic factors or other difficulties, fall ill. Thus the ultimate objective of health promotion is to highlight and facilitate the essential prerequisites for maintaining health.
This approach is central to the CAM perspective on health and underpins all CAM practices.


The "CAM 2020 document can be downloaded here:  cam2020-final.pdf

For more information on EUROCAM see here: http://www.cam-europe.eu/

15 May 2014

Belgian Government legislates to restrict the availability of homeopathy to its citizens

On 29 April 1999, in line with the international and national recommendations on complementary and alternative medical (CAM) therapies expressed by bodies such as the Council of Europe and the European Parliament, the Belgian Parliament voted in the Colla Law in order to initially regulate practitioners of four of the most popular CAM practices in Belgium: acupuncture, chiropractic, homeopathy and osteopathy.

 

In the years to follow professional bodies for these practices were founded and accredited by the Ministry of Health, among which the Liga Homeopathica Classica was established for homeopathy. The Liga established high standards for the education and professional profile of homeopaths in line with the guidelines of the European Central Council of Homeopaths in preparation for an eventual specific legal framework for the profession.

 

Eventually, after legal pressure was brought to bear, the Ministry of Health set up 4 commissions, one for each practice, in order to establish the specific details concerning the regulation the four disciplines. Unfortunately the homeopathy commission was neither democratically constituted, nor did they include adequate representation of the most important interest of all, patients and citizens. 

 

On Monday 12 May 2014, 15 years after the Colla Law was introduced, a Royal Decree was published by the Ministry of Health that completely denies the autonomy of the profession of the homeopath and deprives Belgian patients of their freedom of choice to have homeopathic treatment now and into the future.

 

The final conditions established to be legally allowed to practise homeopathy are:

 

1. practitioners have to be qualified as a medical doctor, dentist or midwife

 

Thereby instantly denying the many homeopathy practitioners in Belgium who have practised for many years and paid into the Belgian taxation system the right to their livelihood.

2. have a degree in homeopathy from an official college or university

 

Nobody in Belgium meets this second condition because homeopathy up until now was only taught in private schools, whether to practitioners or medical doctors. Moreover, the deans of the faculties of medicine have recently declared that homeopathy does not belong in a medical curriculum and refuse to allow it to be taught at their universities. This means that in the future no-one, doctors included, will be able to undertake the required education to be able to practise homeopathy as required by the Law.  

 

A further stipulation says that doctors, dentists and midwives can only prescribe homeopathy for indications for which efficacy is evidence-based. This practically reduces the practice of homeopathy to 'clinical homeopathy' based only on a medical diagnosis, and leaves no room for the holistic and individualised approach of homeopathy that was originally meant to be the ‘added value’ of integrating CAM practices in health care.

 

We regret that Health Minster Mme Onkelinx and the Belgian Government have missed the opportunity to realise the primary objectives of the Colla Law and the spirit in which it was written, and in effect to have completely negated them. In doing so they are completely ignoring the many voices of patients who now cannot consult the homeopath they choose. This reactionary piece of legislation stands in direct contrast to the far more constructive and progressive piece of legislation introduced in Portugal in 2013 that regulates 7 CAM therapies including homeopathy, setting high standards for their education and practice.  (Lei 71/2013)    

 

It is ECCH's view that this unjust execution of the Colla Law must be fought and overturned. To do this we are supporting the call of our Belgian colleagues for financial support to build a legal fighting fund.

 

If you believe the Belgian government have got it wrong please help. Donations to the fighting fund can be transferred to the bank account of the Liga Homeopathica Classica in Belgium: IBAN : BE 75 777 59279 3651  BIC : GKCCBEBB, entitled ‘Help for classical homeopathy’ OR pay through one of the PAYPAL accounts on these two web-sites: http://www.keuzevrijheid.be OR  http://www.ligahomeopatica.be 
 

5 April 2014

ECCH and EUROCAM call on MEP candidates to tackle a major health inequity and support greater integration of CAM into national healthcare systems

ECCH is an active participant in the European platform for Complementary and Alternative Medicine in Europe EUROCAM. EUROCAM recently launched its manifesto for the forthcoming European Parliament elections to be held at the end of May 2014.

Prevalence data reveal a very high use of CAM  by European citizens in their healthcare and there are at least some 300,000 providers of CAM across the EU. Yet, this prevalence is not reflected in EU member states' healthcare provision or in EU legislation. This means that currently there is a clear state of inequity across the EU because most CAM can only be accessed by those who can afford it and those who cannot afford it cannot access it.

National authorities argue that the evidence-base for CAM is not sufficient to support its inclusion in healthcare provision. This is not the case, the evidence -base for CAM's effectiveness and safety is steadily increasing, and, it compares very favourably with that of much of current care provision which has a much weaker evidence base than many like to think. http://clinicalevidence.bmj.com/x/set/static/cms/efficacy-categorisations.html

In our manifesto we call on all European members states to support:
• WHO's call for greater integration of CAM into healthcare systems
• better regulation of CAM's products, practices and providers
• greater investment in researching CAM's risks and benefits.

Please find attached a copy of the full manifesto. If you support its contents please download it and email it to your MEPs and to candidates for the European Parliamentt elections at the end of May, urging them to act to support its contents. Of course should they respond positively to your communication, give them your vote! 

ep election manifesto.pdf


11 March 2014

Dutch Office of Statistics study reveals 22% of 1 million CAM users use homeopathy

A new study published by the Dutch Office of Statistics reveals that between 2010 and 2012 at least one million people used complementary and alternative medicine. Representing some 6% of the population a breakdown of the figures reveals that the main users were women with higher education aged 30 - 65 and that 63% of patients consulted for chronic conditions. The highest use was made of acupuncture by some 25% of respondents but homeopathy came a close second in popularity with 22% of respondents reporting using it. Some general practitioners were reported as prescribing homeopathic medicines in their practice. Satisfaction with CAM practitioners was also recorded as being higher than with general practitioners and medical specialists.

A short magazine article summarising some of the findings can be accessed here:
http://www.nltimes.nl/2014/03/10/1m-visit-alternative-health-care-centers/

A summary the report from the Dutch Office of Statistics in Dutch can be accessed here:
http://www.cbs.nl/nl-NL/menu/themas/gezondheid-welzijn/publicaties/artikelen/archief/2014/2014-4041-wm.htm   

21 January 2014


The Lancet's 2005 Shang et al study shown yet again to be methodologically faulted.

Hahn, a Swedish anesthesiologist and researcher of 30 years experience, who has never studied or practised homeopathy, recently published a new critique of three of the main meta-analyses of homeopathy that are usually cited as not being supportive of a therapeutic effect beyond placebo. Hahn details the Linde (1997), Cucherat (2000) and Shang (2005) analyses, highlighting their flaws and weaknesses.

The Shang et al study, which has been used endlessly by homeopathy's critics to support their flawed cases, has already been shown by other critics to be deeply faulted.  (Ludtke R, Rutten AL: The conclusions on the effectiveness of homeopathy highly depend on the set of analyzed trials. J Clin Epidemiol 2008;61:1197–1204.)

Hahn concludes:  Clinical trials of homeopathic remedies show that they are most often superior to placebo. Researchers claiming the opposite rely on extensive invalidation of studies, adoption of virtual data, or on inappropriate statistical methods. Further work with meta-analyses should abandon the concept of summarizing all available clinical trials and focus on the effects of homeopathy versus placebo or other treatments in specific diseases or groups of diseases. One way to reduce future emotional- driven distortion of evidence by investigators and skeptics would be to separate the evidence-seeking process from the formulation of clinical guidelines more clearly.

For the abstract and to obtain a full copy of the article go here: http://www.karger.com/Article/FullText/355916

Reference: Hahn, R.G., 2013. Homeopathy: Meta-Analyses of Pooled Clinical Data. Forshende Komplementarmedizin; 20(5):376-381

27 November 2013

New Report on the Availability of Homeopathic Medicines in the EU Launched in the European Parliament: the report reveals an unsatisfactory situation


On 26 November Dr Thomas Ulmer MEP (Germany) hosted a meeting in the European Parliament to launch a new report on the availability of homeopathic medicines in Europe. Produced by the European Coalition for Homeopathic and Anthroposophical Medicinal Products (ECHAMP), the report is the result of a comprehensive survey of the situation facing citizens, providers and manufacturers with regards to provision of such medicines in the EU pharmaceutical market. The market for homeopathic and anthroposophic medicinal products is worth 1 billion euros in Europe - with a better regulatory situation it would be much higher,.

Speakers in the meeting included Dr Thomas Ulmer MEP,  Dr. Geseine Klein, President of ECHAMP,  Dr Laurence Girod, Chair of the Heads of Agencies Homeopathic Medicinal Products Working Group (HMPWG) and Mr Tapani Piha for the European Commission DGSANCO.  Following the presentations a number of interventions were made by members of the invited audience.

ECCH General Secretary Stephen Gordon called on the Commission to support the work of the HMPWG which has the difficult task of bringing a harmonised approach to homeopathic medicines by all countries in Europe with insufficient resources to to the job properly. 

The report entitled 'The Availability of Homeopathic and Anthroposophic Medicinal Products in the EU' concludes that:

Demand: There is significant to high demand for homeopathic and anthroposophic medicinal products in at
least two thirds of EU Member States, and this applies to countries both with and without a long term  tradition for these products.

Availability: Availability of registered/authorised homeopathic and anthroposophic medicinal products in the EU is insufficient and the demand cannot always be met. The types of products most widely available in pharmacies are those requested for self-medication.

European legislation: Implementation and enforcement of European medicines legislation for this sector has been slow and is very incomplete even twenty years after its adoption. Divergent implementation, interpretation and enforcement policy in the Member States make it extremely difficult for companies to operate across Europe.

Regulatory environment: The regulatory environment, including assessment capacity and policy at national level, is not proportionate to the large range of stocks and multiple finished medicinal products produced from these stocks, which are used in homeopathic and anthroposophic therapy. In many Member States the number of registered products poorly reflects the high numbers of homeopathic prescribers.

Sustainability: Availability is threatened in some Member States by the lack of a registration process, and in others by an incomplete process for the renewal of existing registrations. The regulatory burden is such that it is not sustainable to maintain registrations for the full range of medicinal products required for proper practice of these therapies.

A copy of the full report and its different annexes can be found here: 

http://www.echamp.eu/publications/special-reports/availability-report.html

1 November 2013

Integrating homeopathy and other complementary approaches improves cancer patients' care

A recent service evaluation study published in the Nursing Times shows that incorporating homeopathy and other forms of complementary care into the care of patients with cancer significantly improves outcomes and the quality of care: The authors conclude: Based on the current data, we propose that complementary therapy interventions make a significant positive difference, regardless of gender, age or patient/carer status. Further studies should be conducted by researchers independent of complementary therapy professions.
A full version of the article is available here: effects-of-complementary-therapies-in-cancer-care_161013.pdf

17 September 2013

Portuguese Government Shows Belgian Government The Error of Its Reactionary Way
On the 2 September 2013 the Health Minister of the Portuguese Government, Paulo Macedo, introduced the enacting legislation that lays down the future legal framework for the regulation of the practice homeopathy and 6 other CAM disciplines in Portugal. Lei 71/2013 is the product of a long process extending over a number of years and clearly sets out the requirements in terms of education and regulation for practitioners of CAM disciplines who do not have a conventional medical training but who wish to practise their discipline competently and responsibly.

The law establishes a framework  that will facilitate the regulated growth of 7 new healthcare professions that will make a valuable contribution to the future healthcare of Portugal's people. Given the current crisis in healthcare precipitated by the failure of whole categories of medicines such as antibiotics, hospital systems under severe strain and the growing burden of chronic disease in an aging population, these new professions will have an increasingly relevant role to play in helping maintain health and treating ill-health effectively in the future.

The new Portuguese law stands in direct contrast to the way the Belgian Minister of Public Health, Ms Laurette Onkelinx has acted in this regulatory arena. In 1999 a perfectly good law, known as the Collas Law,  was introduced onto the Belgian statute books aimed at establishing the regulation of homeopathy and three other disciplines by practitioners in a very similar way to that now achieved by the Portuguese Government. Unfortunately, after a long period in limbo, the law has latterly been through a highly questionable consultation process that has resulted in a perversion the original intention of the law. 

After much lobbying by the Belgian homeopathic doctors the Collas law now defines homeopathy as a 'medical act' and restricts its practice to doctors, dentists and midwives. As a result homeopaths who currently practise in Belgium will now have to stop practising and non-one else can train in the future to be a homeopath in Belgium.  Clearly, while Portugal promotes the future healthcare of its people, Belgium simply protects a small minority of doctors' interests. 

lei_n._71-2013_tnc.pdf   NB The wording of the new Portuguese law begins at the bottom right of the first page. An approximate English translation is available here: port - eng law.pdf


30 June 2013

Complementary and Alternative Medicine – an emerging resource for EU healthcare systems?

There is agreement the EU facing a growing health crisis. An aging population, rising levels of chronic diseases such as cancer, diabetes and heart disease, mental ill-health and anti-microbial resistance are all accentuated by the pressure of austerity on health systems. The situation begs the question as to whether there are other ways to approach healthcare that may be beneficial. In this context a conference entitled ‘Complementary and Alternative Medicine (CAM): An investment in Health ‘ took place in the European Parliament on 27 June 2103.

Jointly organised by two European Parliament interest groups – MEPS against Cancer and MEPS for CAM, the conference was co-hosted and chaired by Alojz Peterle MEP (Slovenia), himself a beneficiary of CAM treatment for cancer, and Sirpa Pietikäinen MEP (Finland).

DGSANCO Commissioner Tonio Borg in his opening keynote speech stated: It is an important principle of the Union's pharmaceutical legislation that patients should have access to the medicinal products of their choice. This includes innovative medicines as much as traditional herbal and homeopathic medicinal products….Patient empowerment is on the increase. It progressively serves to put patients in the driver's seat – taking charge and control of their own health. Patients often know what treatment works for them, and which healthcare is efficient for their condition. This can include the use of complementary medicine.’

The conference heard presentations from expert providers and researchers covering the growing popularity of CAM with citizens, what characterizes CAM’s holistic approach to patient care, the current provision of CAM in the EU and the potential benefits of greater integration into health systems. 

The conference heard there is little coherence in the way member states regulate the estimated 450,000 medical doctors, practitioners and other health professionals practising CAM in the EU. Furthermore, member states’ variable implementation of EU directives for herbal and homeopathic medicinal products is impacting negatively on access by citizens and CAM providers.

Yet recent studies on the economics of CAM seem to indicate its widespread use and integration could result on cost-savings for health systems. One study that involved ‘mining’ the large data-base of Dutch health insurers (1) , appears to show that patients of GPs who use CAM live longer healthier lives and yet cost less in overall care. Evidence for effectiveness and cost-saving was also presented from the pioneering health service in the Tuscany Region in Italy (2) where the widespread integration of CAM across hospital-based healthcare services is having positive impact on patient care and costs. The Tuscany Region is actively involved in the EU European Partnership for Action Against Cancer (EPAAC)  and brings the contribution of CAM in the complementary care of cancer patients to the project discussion table.

In closing MEPs Peterle and Pietikäinen called for the potential contribution of CAM to healthcare in the EU to be taken more seriously by the Commission and member states. They called for the EU to invest more in researching the effectiveness and cost-effectiveness of CAM and to take action to resolve the highly confused and inhibiting regulatory situation that currently exists for products, providers and patients.


References:

1) Patients whose GP knows complementary medicine tend to have lower costs and live longer

Kooreman, Peter; Baars, Erik W.

The European Journal of Health Economics, Volume 13, issue 6 (December 2012), p. 769 - 776.

 

2) http://www.universitasforum.org/index.php/ojs/article/view/69/255



22 April 2013


International Journal of Clinical Practice (IJCP) lowers standards - Part 2


We have been informed by the authors Tournier et al that the full text of their critical letter of response to the original article is now available in pdf from the following link:

http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12138/abstract


15 April 2013

International Journal of Clinical Practice (IJCP) lowers standards

It seems when it comes to homeopathy established journals are ready to lower standards in order to publish negative research information about it - when it comes to positive research articles about homeopathy they are peculiarly resistant to publication at all. e.g. an astounding piece of epidemiological research showing the successful use of a homeopathic preparation in the prevention of seasonally epidemic leptospirosis in a population of 2.5 million in Cuba was refused publication in standard journals and was eventually published in 'Homeopathy' http://www.ncbi.nlm.nih.gov/pubmed/20674839

The International Journal of Clinical Practice has, in our view, lowered the standards of peer-reviewed scientific journalism with the publication of "Adverse effects of homeopathy: a systematic review of published case reports and case series' by Posadzki, I Alotaibi  and E. Ernst in November 2013.  http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12026/abstract

The article was provided 'open access' enabling it to be as widely distributed and read as possible. To be blunt,  in our view the article is an extremely poor piece of academic research work and it is difficult to understand how it got through the peer-review process of the IJCP - unless there were no peer-reviewers with an academic background in homeopathy involved in the review and/or the editor took a 'publish and be damned' attitude.

Along with a number of other authors, ECCH wrote to the IJCP raising a number of concerns about the content of the review. (As the IJCP chose not to publish it, our letter is appended at the end of this editorial). ECCH's letter briefly summarised a number of criticisms that other reviewers have raised in far greater detail. Two of these,including a joint letter from Viksveen, Roberts and Tournier of the Homoepathy Research Institute, have been now published by the IJCP. http://onlinelibrary.wiley.com/doi/10.1111/ijcp.12156/abstract.  Sadly however,  while the original article has been widely disseminated through 'open access'  the replies have not been made 'open access'.

Despite calls to do so, the editor has refused to retract the original article, but instead invites further discussion. In our view at the very least the critical responses should be made as available through 'open access'. To restrict access to these responses to journal subscribers only makes the editor's call for further debate on this poor quality paper seem highly disingenuous.

In the interests of 'open debate' and 'open access', ECCH's letter of response is attached here: ecch - posadski et al ijcp dec 2012.pdf

19 February 2013

Homeopathic Treatment of Migraine in Children: Prospective, Multi-centre, Observational Study shows positive results

Abstract:

Objectives: The study objective was to evaluate the effectiveness of  homeopathic medicines for the prevention and treatment of migraine in children.

Design: This was an observational, prospective, open, non-randomized, non-comparative, multi-center study.

Setting/location: The study was conducted in 12 countries worldwide.

Subjects: Fifty-nine (59) physicians trained in the prescription of homeopathic medicines and 168 children, aged 5–15 years, with definite or probable migraine diagnosed using International Headache Society 2004 criteria were the subjects in this study.

Interventions: Physicians were given complete freedom in terms of treatment prescription; thus, prescriptions were individualized for each patient.

Outcome measures: The frequency, intensity, and duration of migraine attacks in the 3 months prior to inclusion were compared with those during the 3-month follow-up period. Pertinent data were collected using questionnaires completed by the doctor and the patient or his/her parent/guardian. The secondary outcome measure was the impact of homeopathic medicines on education, measured as absence from school.

Results: The frequency, severity, and duration of migraine attacks decreased significantly during the 3-month follow-up period (all p<0.001). Preventive treatment during this time consisted of homeopathic medicines in 98% of cases (mean=2.6 medicines/patient). Children spent significantly less time off school during follow-up than before inclusion (2.0 versus 5.5 days, respectively; p<0.001). The most common preventive medicines used were Ignatia amara (25%; mainly 9C), Lycopodium clavatum (22%), Natrum muriaticum (21%), Gelsemium (20%), and Pulsatilla (12%; mainly 15C). Homeopathy alone was used for the treatment of migraine attacks in 38% of cases. The most commonly used medicines were Belladonna (32%; mainly 9C), Ignatia amara (11%; mainly 15C), Iris versicolor (10%; mainly 9C), Kalium phosphoricum (10%; mainly 9C), and Gelsemium (9%; mainly 15C and 30C).

Conclusions: The results of this study demonstrate the interest of homeopathic medicines for the prevention and treatment of migraine attacks in children. A significant decrease in the frequency, severity, and duration of migraine attacks was observed and, consequently, reduced absenteeism from school.

The Journal of Alternative and Complementary Medicine. February 2013, 19(2): 119-123. doi:10.1089/acm.2011.0821.

http://online.liebertpub.com/doi/abs/10.1089/acm.2011.0821

3 December 2012
Three Year EU CAMbrella Project Holds Final Conference in Brussels

After almost three years of planning, research, consultation and writing, the 1.5 million Euro CAMbrella research project, funded under the EU Commission's FP7 research programme, held its final conference in Brussels on 29 November 2012.  Held in the impressive surroundings of the Bavarian Representation right next door to the European Parliament, the final conference brought together an audience of 150 guests and interested parties to hear short reports from the various work package leaders on the findings and recommendations of each area of research.

Short summarising reports were given based on the themes of the 8 work packages: Terminology, Legal Status, Citizens’ Needs, Patients’ Perspective, Providers’ Perspective, Global Perspective, Research Roadmap and Communications.  The reports are all being presented to the Commission for verification and should hopefully all be ready for public dissemination very soon. For more information  consult: http://www.cambrella.eu/home.php 


11 October 2012

Landmark conference on CAM takes place in the European Parliament

On 9 October 2012 an all day conference entitled ' Complementary and Alternative Medicine - Innovation and Added Value for European Healthcare ' took place in the European Parliament Buildings in the heart of Brussels. Sponsored by three progressive MEPs, Oena Antonescu, Sirpa Pietikäinen and Alojz Peterle the conference speakers presented a very clear rationale for why CAM should become more integrated into EU member state healthcare systems in the near future. ECCH,  together with other participants in the stakeholder group EUROCAM, played an active role in preparing, funding and running this conference.

A short report containing the conference declaration and a list of speakers with access to copies of their presentations is available here:
http://epha.org/a/5387

A pdf of the special report produced for the conference 'Complementary and Alternative Medicine - current status and potential in European Healthcare'  is available here: eu cam booklet.pdf


30 September 2012
Emerging evidence for the cost-effectiveness of complementary therapies and integrative care
 
In a comprehensive systematic review of economic evaluations of CIM aimed at evaluating them for future health reform, 338 economic evaluations were identified of which 204, covering a wide of CIM for different populations, were published between 2001-2010.  The review identified many evaluations previously missed by previous reviews and is without doubt the most comprehensive review of its kind ever undertaken.  It identified emerging evidence of cost-effectiveness and possible cost savings in at least a few clinical populations. The authors conclude that more better quality studies are needed in this important area.

Ref: Are complementary therapies and integrative medicine cost-effective? a systematic review of economic evaluations
Patricia M Herman, Beth L Poindexter, Claudia M Witt, David M Eisenberg
BMJ Open 2012;2:e001046 doi:10.1136/bmjopen-2012-001046

The abstract and full article can be accessed here:
http://bmjopen.bmj.com/content/2/5/e001046.abstract

NOTE: this paper would seem to add to the evidence outlined in a previous paper by Kooreman and Baars published in 2011 in The European Journal of Health Economics entitled "Patients who GP knows Complementary Medicine tend to have lower costs and live longer.

Here a data-set from a Dutch health insurer was used containing quarterly information on healthcare costs (care by general practitioner (GP), hospital care, pharmaceutical care, and paramedic care), dates of birth and death, gender and 6-digit postcode of all approximately 150,000 insurees, for the years 2006–2009. Data from 1913 conventional GPs were compared with data from 79 GPs with additional CAM training in acupuncture (25), homeopathy (28), and anthroposophic medicine (26).

They found that patients whose GP has additional CAM training have 0–30% lower healthcare costs and mortality rates, depending on age groups and type of CAM. The lower costs result from fewer hospital stays and fewer prescription drugs.

Ref: http://link.springer.com/article/10.1007%2Fs10198-011-0330-2

24 August 2012
Study shows patients receiving homeopathy only for influenza-like illness were more satisfied

In a new prospective observational study published in the Journal of Alternative and Complementary Medicine looking at the management of influenza-like illness by allopathic and homeopathic GPs in France, patients receiving homeopathic treatment only recorded most satisfaction with their treatment.
The study was conducted in metropolitan France during the 2009–2010 influenza season and involved   65 homeopathic GPs and 124 allopathic GPs who recruited a total of 461 patients with influenza-like illness. Patient satisfaction with treatment did not differ between both sets of GPs but was highest for patients treated with homeopathic medications only.
The abstract and a full copy of the research paper can be accessed here:
http://online.liebertpub.com/doi/abs/10.1089/acm.2011.0706


7 August 2012
New study shows widespread use of homeopathy in German children

A new study published in 'Pharmacoepidemiology and drug safety' shows that homeopathic medicines, along with phytotherapeutic medicines, are commonly used for German children.  The study's aim was to estimate prevalences and determinants of conventional, homeopathic and phytotherapeutic drugs and expenditures.

Population-based data on drug utilization of 3,642 children revealed 42.3% of the children reported drug use; 24.1% of the drugs were homeopathic and 11.5% were phytotherapeutic. The proportion of children who took at least one homeopathic remedy was 14.3%. Drugs prescribed by physicians were dominated by conventional medicine (76.5%), whereas in non-prescribed drugs, both homeopathy and conventional medicine accounted for 37% each. Boys (OR = 0.78) used less homeopathy than girls. Income showed only a weak influence. Education had a strong effect on the use of phytotherapy such that children of mothers with higher school education (>10 years vs. <10 years) used more phytotherapy (OR = 2.01).

For a copy of the full abstract and access to the full article go to: 

http://onlinelibrary.wiley.com/doi/10.1002/pds.3323/abstract;jsessionid=87C2DC36C5C8687D7CB535D910A57A84.d03t04
 
 

Public Services

If you are a member of the public seeking brief information about homeopathy then you should go to our introductory page.

If you are seeking the services of a qualified and registered homeopath in your particular country then please see if there is a member association of ECCH in your country in the ECCH Members section.

For information about ECCH itself please click here.

 

For Homeopaths

As well as the introductory pages for the members of the public we have developed a number of other web-pages of interest to homeopaths in this section of the site.

Forthcoming seminars and conferences are listed on our News and Events Page.

For any further information on Homeopathy and the Homeopathy Profession please feel free to contact us at ecch@homeopathy-ecch.org

 

© ECCH 2010 All rights reserved.